type here...

CATEGORIES

Press Release

LATEST

1...101112Page 11 of 12

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

FDA Approves THERMOCOOL SMARTTOUCH® SF Ablation Catheter

Medika Life -
The CARTO® 3 System and THERMOCOOL SMARTTOUCH® SF Catheter allow for a patient-tailored ablation approach, resulting in high long-term effectiveness in persistent atrial fibrillation patients

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

Medika Life -
New Non-Profit Organization Focuses on Early-Stage Sponsored Research and Venture Philanthropy to Advance Human Health and Well-being

New Data Shows No Evidence of COVID-19 Spread in Gyms

Medika Life -
Of More than 49.4 Million Health Club Visits, Only 0.0023 Percent Tested Positive for COVID-19

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories